FindTrial
Sign In

Use of homoeopathic medicine and Bach flower medicine for treatment of autism in children.

Management of Autism spectrum disorder in children with individualized homoeopathic remedy versus individualized homoeopathic remedy with Bach flower remedy as an adjuvant :A prospective single blind clinical trial. - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/09/094991
Enrollment
30
Registered
2025-09-17
Start date
Unknown
Completion date
Unknown
Last updated
2025-10-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: F840- Autistic disorder

Interventions

Intervention1: Individualized Homoeopathic Remedy: Patient will be treated with individualized homoeopathic remedy which will be selected on the basis of totality of symptom with particular focus on

Sponsors

Dr Deepalika Sharma
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.Children age 5-12 years . 2.Patient of both the sexes male and female 3.Mild and moderate autism according to ISAA scale 4.Parent able to provide written informed accent .

Exclusion criteria

Exclusion criteria: 1.Severe autism according to ISAA scale. 2. Presence of other neurological disorder. 3.Participation in other clinical trials in past 3 month. 4.Patient age of below 5 year and above 12 years.

Design outcomes

Primary

MeasureTime frame
Improvement in behavioral, cognitive and emotional symptoms in children with ASD, measured using the ISAA pre, mid, and post stage .Timepoint: 6 months—

Secondary

MeasureTime frame
1.Improvement in quality of life in children with ASD. 2.Effectiveness of Bach Flower Remedy as an adjuvant to individualized homoeopathic remedy .Timepoint: 6 months—

Countries

India

Contacts

Public ContactDr Swati R Shinde

Bharati Vidyapeeth (Deemed To Be University)Homoeopathic Medical CollegeAnd Hospital Pune

swati.shinde@bharatividyapeeth.edu9890140393

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026